Business & Finance14 January 2025, 2:12 pm 1 minute
Reuters was two-and-a-half minutes ahead of rivals on Eli Lilly’s unscheduled trading update, which showed fourth-quarter sales of its weight-loss drug Zepbound would miss Wall Street estimates. The drugmaker’s shares slumped 8% on the news.
Article TagsTopics of Interest: Business & FinanceType: Reuters BestSectors: Business & FinanceRegions: AmericasWin Types: SpeedStory Types: Exclusive / ScoopMedia Types: TextCustomer Impact: Important Regional Story
Last Updated:December 10, 2024, 16:20 ISTThe scheme aims to grant scholarships to students from EWS, enhancing their possibilities for further education and employment.The last...
MUMBAI: Private carrier Air India on Tuesday said it has extended its wireless inflight entertainment service to its single-aisle fleet. The service...
Dodge CEO Tim Kuniskis unveils the Charger Daytona SRT concept electric muscle car in Pontiac, Michigan, Aug. 17, 2022.Michael Wayland / CNBCDETROIT — Well-known...
Last Updated:December 10, 2024, 14:12 ISTShares of Religare Enterprises surged nearly 10% after the RBI approved the Burman family's open offer to acquire stakeReligare...